Summitry LLC Has $88.51 Million Position in Agilent Technologies, Inc. $A

Summitry LLC decreased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 666,332 shares of the medical research company’s stock after selling 7,622 shares during the quarter. Agilent Technologies makes up approximately 2.9% of Summitry LLC’s portfolio, making the stock its 8th biggest position. Summitry LLC owned 0.24% of Agilent Technologies worth $88,509,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of A. State Street Corp increased its holdings in Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after purchasing an additional 241,029 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after purchasing an additional 25,139 shares in the last quarter. Morgan Stanley boosted its stake in shares of Agilent Technologies by 15.9% during the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares in the last quarter. Norges Bank bought a new stake in shares of Agilent Technologies during the fourth quarter worth about $549,158,000. Finally, Cantillon Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.8% during the fourth quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of A stock opened at $149.33 on Friday. The stock has a market capitalization of $42.18 billion, a PE ratio of 29.99, a PEG ratio of 2.62 and a beta of 1.25. The business’s 50 day simple moving average is $135.12 and its 200 day simple moving average is $125.40. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Analysts Set New Price Targets

A has been the subject of a number of research reports. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.